Ye Liu
Directeur Général chez OCUMENSION THERAPEUTICS
Fortune : 28 M $ au 30/04/2024
Postes actifs de Ye Liu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OCUMENSION THERAPEUTICS | Directeur/Membre du Conseil | 23/11/2018 | - |
| Directeur Général | 01/08/2018 | - | |
| EYEPOINT PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/01/2021 | - |
Historique de carrière de Ye Liu
Anciens postes connus de Ye Liu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Santen Pharmaceutical (China) Co. Ltd. | Directeur Général | 01/10/2014 | 01/07/2018 |
| Président | 01/10/2014 | 01/07/2018 | |
Eisai China, Inc.
 Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Eisai China, lnc. engages in the manufacture of pharmaceutical products. It offers medicines for digestive, endocrine, orthopedic, and cancer diseases. The company was founded on March 28, 1996 and is headquartered in Suzhou, China. | Directeur Général | 01/02/2009 | 01/09/2014 |
| Corporate Officer/Principal | - | - | |
Sandoz (China) Pharmaceutical Co., Ltd.
 Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz (China) Pharmaceutical Co., Ltd. is a global leader in generic pharmaceuticals and biosimilars. The company is based in Shanghai, China. Sandoz is dedicated to helping patients increase drug accessibility and providing high-quality, affordable healthcare services to more patients worldwide. Founded in 2007, the Chinese company's purpose is to explore new methods of improving and extending people's lives. | Sales & Marketing | 01/10/2006 | 01/02/2009 |
Formation de Ye Liu
| Dalhousie University | Graduate Degree |
| Zhongshan Hospital Fudan University | Undergraduate Degree |
Statistiques
Internationale
| Chine | 6 |
| Canada | 2 |
| Etats-Unis | 2 |
Opérationnelle
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| Chairman | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| OCUMENSION THERAPEUTICS | Health Technology |
| EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Santen Pharmaceutical (China) Co. Ltd. | |
Eisai China, Inc.
Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Eisai China, lnc. engages in the manufacture of pharmaceutical products. It offers medicines for digestive, endocrine, orthopedic, and cancer diseases. The company was founded on March 28, 1996 and is headquartered in Suzhou, China. | Health Technology |
Sandoz (China) Pharmaceutical Co., Ltd.
Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz (China) Pharmaceutical Co., Ltd. is a global leader in generic pharmaceuticals and biosimilars. The company is based in Shanghai, China. Sandoz is dedicated to helping patients increase drug accessibility and providing high-quality, affordable healthcare services to more patients worldwide. Founded in 2007, the Chinese company's purpose is to explore new methods of improving and extending people's lives. | Health Technology |
